FdaApplication
ANDA 212913
Identifiers
- fda_app_no: ANDA212913
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2022-09-12 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SUCRALFATE | SUCRALFATE | 1GM/10ML | SUSPENSION;ORAL |
1 product